SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-145179
Filing Date
2018-05-01
Accepted
2018-05-01 08:31:51
Documents
32
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d558032d10q.htm 10-Q 181528
2 EX-31.1 d558032dex311.htm EX-31.1 6264
3 EX-31.2 d558032dex312.htm EX-31.2 6267
4 EX-32.1 d558032dex321.htm EX-32.1 2788
5 EX-32.2 d558032dex322.htm EX-32.2 2858
  Complete submission text file 0001193125-18-145179.txt   1370458

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20180331.xml EX-101.INS 173653
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20180331.xsd EX-101.SCH 21841
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20180331_cal.xml EX-101.CAL 21526
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20180331_def.xml EX-101.DEF 82601
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20180331_lab.xml EX-101.LAB 173875
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20180331_pre.xml EX-101.PRE 119838
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 18793323
SIC: 8731 Services-Commercial Physical & Biological Research